Home  /  Resource Library  /  Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade

Results of a study investigating ipilimumab and nivolumab for treatment of relapsed Hodgkin lymphoma.